Table 3: Influence of immune cell PD-L1 positivity on evaluation of PD-L1 expression in gastric carcinomas.

 

Number of cases

 

Resection (N=39)

Biopsy (N=39)

TC + only

22 (56.4%)

10 (25.6%)

TC+/IC+

11 (28.2%)

0

Total (CPS1)

33 (84.6%)

10 (25.6%)

*TC +: Tumor cell PD-L1 positivity.

*IC +: Immune cell PD-L1 positivity.